B. Przyklenk
Impact in
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
-
- Cystic Fibrosis Research Advances
- Tracheal and airway disorders
- Neonatal Respiratory Health Research
- Inhalation and Respiratory Drug Delivery
Papers in
-
- Cystic Fibrosis Research Advances 10
- Inhalation and Respiratory Drug Delivery 3
-
- Antifungal resistance and susceptibility 5
- Co-authors
- A. Bauernfeind (18 shared papers)Gerd Hörl (6 shared papers)Félix Ratjen (2 shared papers)Gratiana Steinkamp (2 shared papers)Gerd Döring (2 shared papers)H. von der Hardt (2 shared papers)Karsten Harms (4 shared papers)R. Jungwirth (2 shared papers)
- Journals
- Infection (8 papers)Scandinavian Journal of Gastroenterology (2 papers)Pediatric Pulmonology (2 papers)Shock (1 paper)Serodiagnosis and Immunotherapy in Infectious Disease (3 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
B. Przyklenk
17 papers receiving 380 citations
Peers
Comparison fields: 5 of 48
- Molecular Medicine 48
- Pulmonary and Respiratory Medicine 275
- Endocrinology 35
- Infectious Diseases 80
- Critical Care and Intensive Care Medicine 16
Countries citing papers authored by B. Przyklenk
This map shows the geographic impact of B. Przyklenk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Przyklenk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Przyklenk more than expected).
Fields of papers citing papers by B. Przyklenk
This network shows the impact of papers produced by B. Przyklenk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Przyklenk. The network helps show where B. Przyklenk may publish in the future.
Co-authors
The 15 scholars most cited alongside B. Przyklenk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 157 | |
| 2 | 1987 | 124 | |
| 3 | 1987 | 28 | |
| 4 | 1990 | 22 | |
| 5 | 1987 | 10 | |
| 6 | 1988 | 10 | |
| 7 | 1998 | 9 | |
| 8 | 1987 | 8 | |
| 9 | 1989 | 8 | |
| 10 | 1990 | 6 | |
| 11 | 1990 | 6 | |
| 12 | 1988 | 6 | |
| 13 | 1988 | 5 | |
| 14 | Microbiological background for anti-Pseudomonas aeruginosa vaccination in cystic fibrosis. | 1997 | 4 |
| 15 | 1990 | 4 | |
| 16 | 1987 | 3 | |
| 17 | 1988 | 1 | |
| 18 | 1997 | 1 | |
| 19 | [Antibacterial antibodies in immunoglobulins]. | 1985 | 1 |
About B. Przyklenk
B. Przyklenk is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases, Molecular Biology, Molecular Medicine and Surgery, having authored 19 papers that have together received 413 indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (10 papers), Antifungal resistance and susceptibility (5 papers), Bacterial biofilms and quorum sensing (5 papers), Antibiotic Resistance in Bacteria (5 papers), Helicobacter pylori-related gastroenterology studies (4 papers), Inhalation and Respiratory Drug Delivery (3 papers), Eosinophilic Esophagitis (3 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). The work is most often cited by research in Molecular Medicine (48 citations), Pulmonary and Respiratory Medicine (275 citations), Endocrinology (35 citations), Infectious Diseases (80 citations) and Critical Care and Intensive Care Medicine (16 citations). B. Przyklenk has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include A. Bauernfeind, Gerd Hörl, Félix Ratjen, Gratiana Steinkamp, Gerd Döring, H. von der Hardt, Karsten Harms, R. Jungwirth, C. Petermüller and Richard V. Goering. Their work appears in journals such as Infection, Scandinavian Journal of Gastroenterology, Pediatric Pulmonology, Shock and Serodiagnosis and Immunotherapy in Infectious Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.